Crinetics News

Crinetics Pharmaceuticals Strengthens Leadership With New Appointment

TipRanksDec 16 16:55 ET

Crinetics Pharmaceuticals Analyst Ratings

BenzingaDec 16 09:46 ET · Ratings

Neurocrine's Drug Gains FDA Nod As First Targeted Treatment For Certain Type Of Inherited Disorder, Analyst Highlights Blockbuster Potential

Analyst UpgradesDec 16 09:10 ET

Express News | Crinetics Pharmaceuticals Appoints Isabel Kalofonos as Chief Commercial Officer

ReutersDec 16 08:00 ET

Press Release: Crinetics Pharmaceuticals Appoints Isabel Kalofonos as Chief Commercial Officer

Dow JonesDec 16 08:00 ET

JMP Securities Maintains Crinetics(CRNX.US) With Buy Rating, Maintains Target Price $87

Moomoo NewsDec 16 00:32 ET · Ratings

Analysts Offer Insights on Healthcare Companies: Crinetics Pharmaceuticals (CRNX) and Addus Homecare (ADUS)

TipRanksDec 16 00:30 ET · Ratings

Crinetics Pharmaceuticals Grants Stock Options to New Employees Under 2021 Inducement Plan

Quiver QuantitativeDec 10 20:50 ET

Express News | Crinetics Pharmaceuticals Announces December 2024 Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

ReutersDec 10 20:44 ET

Crinetics Pharmaceuticals Announces December 2024 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswireDec 10 20:44 ET

JMP Securities Maintains Crinetics(CRNX.US) With Buy Rating, Raises Target Price to $87

Moomoo NewsDec 9 10:31 ET · Ratings

Crinetics Announces FDA Acceptance of NDA for Paltusotine

TipRanksDec 9 09:38 ET

Express News | Crinetics Pharmaceuticals Inc - FDA Targets Pdufa Date Sept 25, 2025 for Nda Review Completion

ReutersDec 9 08:04 ET

Express News | Crinetics Announces FDA Acceptance of New Drug Application for Paltusotine for Adult Patients With Acromegaly

ReutersDec 9 08:00 ET

Cushing Syndrome Pipeline Insight 2024, Featuring Key Players Corcept Therapeutics, Sparrow Pharmaceuticals, Crinetics Pharmaceuticals and Key Products Relacorilant, SPI 62 and CRN-04894

Yahoo FinanceDec 6 04:14 ET

Crinetics Price Target Raised to $87 From $80 at JMP Securities

TipRanksDec 5 06:40 ET

Analysts Conflicted on These Healthcare Names: Lexicon Pharmaceuticals (LXRX), Halozyme (HALO) and Crinetics Pharmaceuticals (CRNX)

TipRanksNov 27 00:42 ET · Ratings

LifeSci Capital Maintains Crinetics(CRNX.US) With Buy Rating, Maintains Target Price $82

Moomoo NewsNov 22 15:31 ET · Ratings

Promising Outlook for Crinetics Pharmaceuticals' Paltusotine in Phase 3 Trial Drives Buy Rating

TipRanksNov 22 14:35 ET · Ratings

Crinetics Pharmaceuticals to Participate in Three Upcoming December Investor Conferences

GlobeNewswireNov 15 09:00 ET